Elliot Shapiro’s practice is transaction-oriented, with a focus on corporate and securities law, public and private M&A, infrastructure and P3 financing, as well as venture capital financing transactions. Mr. Shapiro also regularly advises public companies and their boards of directors on strategic, disclosure and governance matters. He has also worked on various licensing and related commercial arrangements. Mr. Shapiro has been integrally involved in numerous cross-border Canada-US corporate finance transactions both on a public and private placement basis, as well as a range of public and private M&A transactions. Mr. Shapiro is co-chair of our Canadian corporate finance and securities team and a member of the Corporate Finance Advisory Committee of the Québec Autorité des marchés financiers. Mr. Shapiro also serves as a member of Norton Rose Fulbright’s Canadian Risk and Audit Committee, and he previously served for over five years as Corporate Secretary of a specialty biopharmaceutical company traded on the Toronto Stock Exchange and the Nasdaq Capital Market. In October 2019, Mr. Shapiro was named as one of Canada’s leading infrastructure lawyers by Lexpert.
On January 10, 2019, a consortium consisting of Air Canada, Toronto-Dominion Bank (“TD”), Canadian Imperial Bank of Commerce (“CIBC”) and Visa Canada Corp. (“Visa”) announced the successful closing of its purchase of Aimia Canada Inc., owner and operator of the Aeroplan Loyalty Business, from Aimia Inc.
On March 7, 2018, Industrial Alliance Insurance and Financial Services Inc. (iA Financial Group) completed a bought deal public offering of 2,500,000 Common Shares (the Common Shares) and a concurrent bought deal public offering of 6,000,000 Non-Cumulative 5-Year Rate Reset Class A Preferred Shares Series I (the Series I Preferred Shares).
On June 28, 2018, SNC-Lavalin’s infrastructure investment fund, SNC-Lavalin Infrastructure Partners LP (the Fund), completed the previously announced transfer of a fifth Canadian infrastructure asset, the McGill University Health Centre in Montréal.
On March 2, 2018, SNC-Lavalin Group Inc. (SNC-Lavalin) completed a private offering of $525-million aggregate principal amount three series of debentures, consisting of (i) $150,000,000 of its Floating Rate Series 2 Debentures due March 4, 2019; (ii) $175,000,000 of its Floating Rate Series 3 Debentures due March 2, 2021; and (iii) $200,000,000 of its 3.235 per cent Series 4 Debentures due March 2, 2023 (collectively, the Debentures).